Related by context. Frequent words. (Click for all words.) 52 Make Normal Course 52 Special Shareholder Meeting 51 TranSwitch indebtedness 51 Issuer Bid 51 Eduard Korsinsky Esq 51 JOINT PROXY STATEMENT PROSPECTUS 51 maximizing stockholder 51 Safe Harbor Provision 51 Annual Meeting Date 50 theCompany 50 THE OFFER 50 Statutory Basis 50 INVESTORS AND SECURITY HOLDERS 50 -leukemias 50 Vertex Pharmaceuticals Announces 50 IMPORTANT INFORMATION 50 PLIVA acquisition 50 symbol TOL 50 SEC 'S WEBSITE 50 Proposed Settlement 49 symbol GGP 49 Resverlogix Corp. 49 FINANCIAL CONDITION AND 49 Repurchase Program 49 Shelf Registration Statement 49 d Represents 49 Amended Offer 49 www.labopharm.com 49 Company Nasdaq PRGO 49 Stock Repurchase Plan 49 Common Share Offering 49 Restricted Voting Shares 49 Declares Quarterly Dividends 49 HLTH Corporation 49 pershare 48 Completes Tender Offer 48 INVESTMENT ADVICE 48 Share Repurchase Plan 48 Final Prospectus 48 unitholder approval 48 theSecurities 48 D Cumulative Redeemable 48 Files Annual Report 48 www.dundeereit.com 48 Offer Documents 48 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 48 Shareholder Rights 48 Reverse Takeover 48 Private Placement Offering 48 * Potentially libelous 48 www.delcath.com 48 Management Proxy Circular 48 risks anduncertainties 48 NASDAQ Listing Rules 48 Goldfarb Branham Law Firm 48 Adopts Shareholder Rights 48 Warrant Exercise 48 Q2 Loss Widens 48 Combination Agreement 48 Second Tranche 48 UNITED STATES SECURITIES ACT 48 & Fistel LLC 48 Preliminary Prospectus 48 normalized FFO 48 Share Repurchases 47 Revised Offer 47 CCAA proceedings 47 OR OTHER PROFESSIONAL FINANCIAL 47 OR SIMILAR STATEMENTS ARE 47 Shareholder Approval 47 THE ADEQUACY OR ACCURACY 47 inVentiv Health Inc. 47 STATEMENTS AND 47 Stockholders Approve Merger 47 Normal Course Issuer Bid 47 Futuremed 47 BlackRock Kelso Capital 47 THIS NEWS RELEASE 47 LOOKING STATEMENTS 47 Extends Tender Offer 47 Rule #a 8 47 Stapled Units 47 Share Repurchase Program 47 Caremark stockholders 47 Hold Third Quarter 47 Centerline Holding Company 47 Private Placement Financing 47 Previously Announced 47 ANY WAY WITHOUT 47 Stockholder Rights Plan 47 Explore Strategic Alternatives 47 THE TERMS AND CONDITIONS 47 SECURITIES AND EXCHANGE COMMISSION 47 Q2 Loss Narrows 47 TheCompany 47 IS DEFINED IN 47 underwriters overallotment option 47 Genitope Corporation 47 TintinaGold 47 NCIB 47 Prospectus Supplement